Diligence memo · auto-generated · as of July 3, 2026

Vesalius Longevity Labs (Canada) Inc.

Vesalius Longevity Labs (Canada) Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Vesalius Longevity Labs (Canada) Inc. operates in Software / Tech, based in VANCOUVER.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Vesalius Longevity Labs (Canada) Inc. has raised $168K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $168K on 2025-05-23.

Most recent recorded round closed around 2025-05-23.

Valuation (modeled)modeled

Provath models Vesalius Longevity Labs (Canada) Inc. at approximately $501K (range $110K–$1.3M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.51× the median modeled value of Pre-Seed Software / Tech companies in 2025–2027 (105 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 13 mo ago; this sector typically re-raises about every 13 months.

Raising on or ahead of the sector's normal rhythm.

Comparablesmixed

Capital scale ranks ahead of 7% of Software / Tech peers (3920 compared).

Modeled value ranks above 3% of those peers.

Closest niche peers: 1486 Labs LLC, Imagen Digital Dentistry Support Services, LLC, Quarion Technology Inc., 3rd-i Technology, Inc., Simulacra Data, Inc..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.